Pax Neuroscience
PrivateLast Round
Grant
Jan 1, 2022
Total Funding Raised
$1.57M
Company Overview
Pax Neuroscience operates in Healthcare & Life Sciences and is based in Rockville, Maryland. Its latest recorded funding round was a Grant round in January 2022.
Pax Neuroscience is a biotechnology company that develops protein biomarker-based clinical laboratory services for the diagnosis and treatment of depression.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Mental Health, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pax Neuroscience Comparables
Compare Pax Neuroscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MindX Sciences | 81% | |
| Circular Genomics | 79% | |
| Atlantic Diagnostic Laboratories | 77% |
For institutional investors. Book with your work email.
Pax Neuroscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 1, 2022 | ||||
| Grant | Sep 4, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pax Neuroscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Mental Health | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 135% MoM.
- May 3, 2025
Monthly visitors increased 114% MoM.
For institutional investors. Book with your work email.
Pax Neuroscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pax Neuroscience's valuation, stock price, and market status.
Is Pax Neuroscience a public or private company?
Pax Neuroscience is a private company.
What is the current stock price of Pax Neuroscience?
Pax Neuroscience is a private company, so its shares have no public market price. Caplight tracks Pax Neuroscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pax Neuroscience worth (valuation)?
Valuation information for Pax Neuroscience is not publicly available.
Can I buy Pax Neuroscience stock?
Pax Neuroscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pax Neuroscience's last funding round?
Pax Neuroscience's most recent funding round was Grant on January 1, 2022.
Who are the main investors in Pax Neuroscience?
Key investors in Pax Neuroscience include National Institute of Mental Health.
Will Pax Neuroscience IPO soon?
No public IPO plans have been announced for Pax Neuroscience.
How can I track Pax Neuroscience secondary market activity?
Caplight tracks bids, offers, and trades in Pax Neuroscience's shares on secondary markets.